Examination of the estrogenicity of 2,4,6,2',6'-pentachlorobiphenyl (PCB 104), its hydroxylated metabolite 2,4,6,2',6'-pentachloro-4-biphenylol (HO-PCB 104), and a further chlorinated derivative, 2,4,6,2',4',6'-hexachlorobiphenyl (PCB 155)

Environmental Health Perspectives

Volumn 105, Issue 11, 1997, Pages 1238-1248

  Fielden, Mark R ^a   Chen, Ih ^b   Chittim, Brock ^c   Safe, Stephen H ^b   Zacharewski, Timothy R ^a,d  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b TEXAS A AND M UNIVERSITY   (United States)

^c Research Division   (Canada)

^d Michigan State University   (United States)

Author keywords

Environmental estrogen; Estrogen receptor; Estrogenicity; Hydroxylation; In vitro; In vivo; Polychlorinated biphenyls

Indexed keywords

2,2',4,4',6,6' HEXACHLOROBIPHENYL; 2,4,6,2',6' PENTACHLORO 4 BIPHENYLOL; 2,4,6,2',6' PENTACHLOROBIPHENYL; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; LUCIFERASE; POLYCHLORINATED BIPHENYL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; EPITHELIUM CELL; ESTROGEN ACTIVITY; FEMALE; GAS CHROMATOGRAPHY; GENE EXPRESSION; HUMAN; HUMAN CELL; HYDROXYLATION; MASS SPECTROMETRY; MOUSE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RECEPTOR BINDING; REPORTER GENE; UTERUS; VAGINA;

ANIMALIA; MINK CELL FOCUS-FORMING VIRUS;

EID: 0031440187     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.971051238     Document Type: Article

References (115)

1. Beato M. Gene regulation by steroid hormones. Cell 56:335-344 (1989).
2. Evans R. The steroid and thyroid hormone receptor superfamily. Science 240:889-895 (1988).
3. Henderson BE, Ross R, Bernstein L. Estrogens as a cause of human cancer. Cancer Res 48:246-253 (1988).
4. Yager JD, Liehr JG. Molecular mechanisms of estrogen carcinogenesis. Ann Rev Pharmacol Toxicol 36:203-232 (1996).
5. Dickson RB, Thompson EW, Lippman ME. Regulation of proliferation, invasion and growth factor synthesis in breast cancer by steroids. J Steroid Biochem Mol Biol 37:305-316 (1990).
6. Imagawa I, Bandyopadhyay GK, Nandi S. Regulation of mammary epithelial cell growth in mice and rats. Endocrinol Rev 11:494-523 (1991).
7. Lippman ME, Dickson RB. Mechanisms of growth control in normal and malignant breast epithelium. Recent Prog Horm Res 45:383-440 (1989).
8. Rochefort H. Oestrogen- and anti-oestrogen-regulated genes in human breast cancer. In: Non-reproductive Actions of Sex Steroids. Ciba Foundation Symposium, vol 191. New York:John Wiley & Sons, 1995;254-268.
9. Gray LE, Kelce WR, Wiese T, Tyl R, Gaido K, Cook J, Klinefelter G, Desaulniers D, Wilson E, Zacharewski T. Endocrine Screening Methods Workshop report: detection of estrogenic and androgenic hormonal and antihormonal activity for chemicals that act via receptor or steroidogenic enzyme mechanisms. Reprod Toxicol (in press).
10. Colborn T, vom Saal FS, Soto AM. Develop-mental effects of endocrine-disrupting chemicals in wildlife and humans. Environ Health Perspect 101:378-384 (1993).
11. Davis DL, Bradlow HL, Wolff M, Woodruff T, Hoel DG, Anton-Culver H. Medical hypothesis xenoestrogens as preventable causes of breast cancer. Environ Health Perspect 101:372-377 (1993).
12. Safe SH. Environmental and dietary estrogens and human health: is there a problem? Environ Health Perspect 103:346-351 (1995).
13. Katzenellenbogen JA. The structural pervasiveness of estrogenic action. Environ Health Perspect 103 (suppl 7):99-101 (1995).
14. Reel JR, Lamb JC, Neal BH. Survey and assessment of mammalian estrogen biological assays for hazard characterization. Fundam Appl Toxicol 34:288-305 (1996).
15. Zacharewski T. In vitro assays used to assess estrogenic substances. Environ Sci Technol 31:6-623 (1997).
16. Kimbrough RD. Polychlorinated biphenyls (PCBs) and human health: an update. Crit Rev Toxicol 25:133-136 (1995).
17. McFarland VA, Clarke JU. Environmental occurrence, abundance, and potential toxicity of polychlorinated biphenyl congeners: considerations for a congener-specific analysis. Environ Health Perspect 81:225-239 (1989).
18. Safe SH. Polychlorinated biphenyls (PCBs): environmental impact, biochemical and toxic respons- es, and implications for risk assessment. Crit Rev Toxicol 24:87-149 (1994).
19. Brown AP, Ganey PE. Neutrophil degranulation and superoxide production induced by polychlorinated biphenyls are calcium dependent. Toxicol Appl Pharmacol 131:198-205 (1995).
20. Ganey PE, Sirois JE, Denison M, Robinson JP, Roth RA. Neutophil function after exposure to polychlorinated biphenyls in vitro. Environ Health Perspect 101:430-434 (1993).
21. Kodavanti PR, Shin D-S, Tilson HA, Harry GJ. Comparative effects of two polychlorinated biphenyl congeners on calcium homeostasis in rat cerebellar granule cells. Toxicol Appl Pharmacol 123:97-106 (1993).
22. Shain W, Bush B, Seegal R. Neurotoxicity of polychlorinated biphenyls: structure-activity relationships of individual congeners. Toxicol Appl Pharmacol 111:33-42 (1991).
23. Wong PW, Pessah IN. ortho-Substituted polychlorinated biphenyls alter calcium regulation by a ryanodine receptor-mediated mechanism: structural specificity toward skeletal- and cardiac-type calcium release channels. Mol Pharmacol 49:740-751 (1996).
24. Andersson O, Nordlunk-Muller L, Barnes HJ, Lund J. Heterologous expression of human utero-globin/polychlorinated biphenyl-binding protein. J Biol Chem 269:19081-19087 (1994).
25. Brouwer A, Blaner WS, Kukler A, Van Den Berg KJ. Study of the mechanism of interference of 3,3′,4,4′-tetrachlorobiphenyl with the plasma retinol-binding proteins in rodents. Chem Biol Interactions 68:203-217 (1988).
26. Battershill JM. Review of the safety assessment of polychlorinated biphenyls (PCBs) with particular reference to reproductive toxicity. Hum Exp Toxicol 13:581-597 (1994).
27. Safe S. Toxicology, structure-function relationship, and human and environmental health impacts of polychlorinated biphenyls: progress and problems. Environ Health Perspect 100:259-268 (1992).
28. Sauer PJJ, Huisman M, Koopman-Esseboom C, Morse DC, Smits-van Prooije AE, van de Berg KJ, Tuinstra LGMT, van der Paauw CG, Boersma ER, Weisglas-Kuperus N. Effects of polychlorinated biphenyls (PCBs) and dioxins on growth and development. Hum Exp Toxicol 13:900-906 (1994).
29. Waller CL, Minor DL, McKinney JD. Using three dimensional quantitative structure - activity relationships to examine estrogen receptor binding affinities of polychlorinated hydroxybiphenyls. Environ Health Perspect 103:702-707 (1995).
30. Korach KS, Sarver P, Chae K, McLachlan JA, McKinney JD. Estrogen receptor-binding activity of polychlorinated hydroxybiphenyls: conformationally restricted structural probes. Mol Pharmacol 33:120-126 (1988).
31. Gierthy JF, Arcaro KF, Floyd M. Assessment and implications of PCB estrogenicity. Organohalogen Compounds 25:419-423 (1995).
32. 3H]estradiol binding on rat uterine receptor. Biochem Pharmacol 23:447-451 (1974).
33. Nesaretnam K, Corcoran D, Dils RR, Darbre P. 3,4,3′,4′-Tetrachlorobiphenyl acts as an estrogen in vitro and in vivo. Mol Endocrinol 10:923-936 (1996).
34. Soto AM, Sonnenschein C, Chung KL, Fernandez, MF, Olea N, Olea Serrano F. The E-SCREEN assay as a tool to identify estrogens: an update on estrogenic environmental pollutants. Environ Health Perspect 103 (suppl 7):113-122 (1995).
35. Vonier PM, Grain DA, McLachlan JA, Guillette LJ, Arnold SF. Interaction of environmental chemicals with the estrogen and progesterone receptors from the oviduct of the American alligator. Environ Health Perspect 104:1318-1322 (1996).
36. Bitman J, Cecil HC. Estrogenic activity of DDT analogs and polychlorinated biphenyls. J Agric Food Chem 18:1108-1112 (1970).
37. Ecobichon DJ, MacKenzie DO. The utero-trophic activity of commercial and isomerically pure chlorobiphenyls in the rat. Res Commun Chem Pathol Pharmacol 9:85-95 (1974).
38. Gellert R. Uterotrophic activity of polychlorinated biphenyls (PCBs) and induction of precocious reproductive aging in neonatally treated female rats. Environ Res 16:123-130 (1978).
39. Jansen HT, Cooke PS, Porcelli J, Liu T-C, Hansen LG. Estrogenic and antiestrogenic actions of PCBs in the female rat: in vitro and in vivo studies. Reprod Toxicol 7:237-248 (1993).
40. Li M-H, Hansen LG. Enzyme induction and acute endocrine effects in prepubertal female rats receiving environmental PCB/PCDF/PCDD mixtures. Environ Health Perspect 104:712-722 (1996).
41. Orberg J, Kihlstrom JE. Effects of long-term feeding of polychlorinated biphenyls (PCB, Clophen A60) on the length of the estrus cycle and on the frequency of implanted ova in the mouse. Environ Res 6:176-179 (1973).
42. Soontornchat S, Li MH, Cooke PS, Hansen LG. Toxicokinetic and toxicodynamic influences on endocrine disruption by polychlorinated biphenyls. Environ Health Perspect 102:568-571 (1994).
43. Bulger WH, Feil VJ, Kupfer D. Role of hepatic monooxygenases in generating estrogenic metabolites from methoxychlor and from its identified contaminants. Mol Pharmacol 27:115-124 (1985).
44. Schneider SL, Alks V, Morreal CE, Sinha DK, Dao TL. Estrogenic properties of 3,9-dihydroxy-benz[a]anthracene, a potential metabolite of benz[a]anthracene. J Natl Cancer Inst 57:1351-1354 (1976).
45. Arnold SF, Klotz DM, Collins BM, Vonier PM, Guillette Jr. LJ, McLachlan JA. Synergistic activation of estrogen receptor with combinations of environmental chemicals. Science 272:1489-1492 (1996).
46. Connor K, Ramamoorthy K, Moore M, Mustain M, Chen I, Safe S, Zacharewski T, Gillesby B, Joyeux A, Balaguer P. Hydroxylated polychlorinated biphenyls (PCBs) as estrogens and antiestrogens: structure - activity relationships. Toxicol Appl Pharmacol 145:111-123 (1997).
47. Moore M, Mustain M, Daniel K, Chen I, Safe S, Zacharewski T, Gillesby B, Joyeux A, Balaguer P. Antiestrogenic activity of hydroxylated polychlorinated biphenyl congeners identified in human serum. Toxicol Appl Pharmacol 142:160-168 (1997).
48. Dewailly E, Dodin S, Verreault R, Jacgues M, Brisson J. High organochlorine body burden in women with estrogen receptor-positive breast cancer. J Nad Cancer Inst 86:232-234 (1994).
49. Falck F, Ricci A, Wolff MS, Godbold J, Deckers P. Pesticides and polychlorinated biphenyl residues in human breast lipids and their relation to breast cancer. Arch Environ Health 47:143-146 (1992).
50. Davis DL, Bradlow HL. Can environmental estrogens cause breast cancer? Sci Am (October): 167-172 (1995).
51. Sharpe RM, Skakkebaek NE. Are estrogens involved in falling sperm counts and disorders of the male reproductive tract. Lancet 341:1392-1395 (1993).
52. Krieger N, Wolff MS, Hiatt RA, Rivera M, Vogelman J, Orentreich N. Breast cancer and serum organochlorines: a prospective study among white, black and Asian women. J Nad Cancer Inst 86:589-599 (1994).
53. Mussalo-Rauhamaa H, Hasanen E, Pyysalo H, Antervo K, Kaupila R, Pantzar P. Occurence of beta-hexachlorocyclohexane in breast cancer patients. Cancer 66:2124-2128 (1990).
54. Unger M, Kiaer H, Blichert-Toft M, Olsen J, Clausen J. Organochlorine compounds in human breast fat from deceased patients with and without breast cancer and in biopsy material from newly diagnosed patients undergoing breast surgery. Environ Res 34:24-28 (1984).
55. Wolff MS, Toniolo PG, Lee EW, Rivera M, Dubin N. Blood levels of organochlorine residues and risk of breast cancer. J Natl Cancer Inst 85:648-652(1993).
56. Adami H-O, Lipworth L, Titus-Ernstoff L, Hsieh C-C, Hanberg A, Ahlborg U, Baron J. Organochlorine compounds and estrogen-related cancers in women. Cancer Causes Control 6:551-566 (1995).
57. Krishnan V, Safe S. Polychlorinated biphenyls (PCBs), dibenzo-p-dioxins (PCDDs) and dibenzofuran (PCDFs) as antiestrogens in MCF-7 human breast cancer cells: quantitative structure - activity relationships. Toxicol Appl Pharmacol 120:55-61 (1993).
58. Safe S. Modulation of gene expression and endocrine response pathways by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Pharmacol Ther 67:247-281 (1995).
59. Mullin MD, Pochini CM, McCrindle S, Romkes M, Safe S, Safe L. High resolution PCB analysis: the synthesis and Chromatographic properties of all 209 PCB congeners. Environ Sci Tech 18:468-476 (1984).
60. Safe S, Washburn K, Zacharewski T, Phillips T. Synthesis and characterization of hydroxylated polychlorinated biphenyls (PCBs) identified in human serum. Chemosphere 31:3017-3023 (1995).
61. Laws SC, Carey SA, Kelce WR, Cooper RL, Gray LE. Vinclozolin does not alter progesterone receptor (PR) function in vivo despite inhibition of PR binding by its metabolites in vitro. Toxicology 110:1-11 (1996).
62. Balaguer P, Joyeux A, Denison M, Vincent R, Gillesby B, Zacharewski T. Assessing the estrogenic and dioxin-like activities of chemicals and complex mixtures using in vitro recombinant receptor/reporter gene assays. Can J Physiol Pharmacol 74:216-222 (1996).
63. Connor K, Howell J, Chen I, Liu H, Berhane K, Sciarretta C, Safe S, Zacharewski T. Failure of chloro-S-triazine-derived compounds to induce estrogen receptor-mediated responses in vivo and in vitro. Fundam Appl Toxicol 30:93-101 (1995).
64. Zacharewski T, Berhane K, Gillesby B, Burnison K. Detection of estrogen- and dioxin-like activity in pulp and paper mill black liquor effluent using in vitro recombinant receptor/reporter gene assays. Environ Sci Tech 29:2140-2146 (1995).
65. Sambrook J, Fristch EF, Maniatis T. Molecular Cloning. A Laboratory Manual. New York:Cold Spring Harbor Laboratory Press, 1989.
66. Berry M, Metzger D, Chambon P. Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonist activity of the anti-oestrogen 4-hydroxytamoxifen. EMBO J 9:2811-2818 (1990).
67. Brasier AR, Tate JE, Habener JF. Optimized use of the firefly luciferase assay as a reporter gene in mammalian cell lines. Biotechniques 7:1116-1122 (1989).
68. Terenius L. The Allen-Doisy test for estrogens investigated. Steroids 17:653-661 (1971).
69. Hopper MI. Methylation of chlorophenoxy acid herbicide and pentachlorophenol residues in food using ion-pair alkylation. J Agric Food Chem 35:265-269 (1987).
70. Sandau CD, Norstrom RJ. Determination of hydroxy-PCBs and preliminary results from polar bear blood plasma. Organohalogen Compounds: 412-417 (1996).
71. Clemons JH, Marvin CR, Wu ZF, McCarry BE, Allan L, Bryant DW, Zacharewski TR. Identification of estrogen- and dioxin-like activities in urban air particulate matter using recombinant receptor/reporter gene bioassays. In: 17th Annual Meeting of the Society of Environmental Toxicology and Chemistry, Washington, DC, 1996;211(490).
72. Meek MD, demons J, Wu ZF, Fielden MR, Zacharewski T. In vitro and in vivo assessments of the alleged estrogen receptor-mediated activities of phthalate esters [abstract]. Fundam Appl Toxicol 36(1, Pt 2):295 (1997).
73. Ruh MF, Zacharewski T, Connor K, Howell J, Chen I, Safe S. Naringenin: a weak estrogenic bioflavonoid that exhibits antiestrogenic activity. Biochem Pharmacol 50:1485-1493 (1995).
74. Billings RE, McMahon RE. Microsomal biphenyl hydroxylation: the formation of 3-hydroxybiphenyl and biphenyl catechol. Mol Pharmacol 14:145-154 (1978).
75. Kaminsky LS, Kennedy MW, Adams SM, Guengerich FP. Metabolism of dichlorobiphenyls by highly purified isozymes of rat liver cyttochrome P-450. Biochemistry 20:7379-7384 (1981).
76. Welch RM, Levin W, Conney H. Estrogenic action of DDT and its analogs. Toxicol Appl Pharmacol 14:358-367 (1969).
77. Villalobos M, Olea N, Brotons JA, Olea-Serrano MF, Ruiz de Almodovar JM, Pedraza V. The E-Screen assay: a comparison of different MCF-7 cell stocks. Environ Health Perspect 103:844-850 (1995).
78. Wiese TE, Kral LG, Dennis KE, Butler WB, Brooks SC. Optimization of estrogen growth response in MCF-7 cells, In vitro Cell Dev Biol 28A:595-602 (1992).
79. Anderson JN, Peck EJ, Clark JH. Estrogen-induced uterine response and growth: relationship to estrogen receptor binding by uterine nuclei. Endocrinology 96:160-167 (1975).
80. Brooks SC, Wappler NL, Corombos JD, Doherty LM, Horwitz JP. Estrogen structure - -receptor function relationships. In: Recent Advances in Steroid Hormone Action (Moudgil VK, ed). Berlin:Walter de Gruyter & Co., 1987;443-446.
81. Gorski J, Raker B. Estrogen action in the uterus: the requisite for sustained estrogen binding in the nucleus. Gynecol Oncol 2:249-258 (1974).
82. Lan NC, Katzenellenbogen BS. Temporal relationships between hormone receptor binding and biological responses in the uterus: studies with short -and long-acting derivatives of estradiol. Endocrinology 98:220-227 (1976).
83. Astwood EB. Estrogens and progestins. In: The Pharmacological Basis of Therapeutics (Goodman LS, Gilamn A, eds). 4th Ed. Toronto: The MacMillan Company, 1970; 1538-1565.
84. Hisaw FL, Comparative effectiveness of estrogens on fluid imbibition and growth of the rat's uterus. Endocrinology 54:276-289 (1959).
85. Jones RC, Edgren RA. The effects of various steroids on the vaginal histology in the rat. Fertil Steril 24:284-291 (1973).
86. Gellert RJ. Kepone, Mirex, Dieldrin and Aldrin: estrogenic activity and the induction of persistent vaginal estrus and anovulation in rats following neonatal treatment. Environ Res 16:131-138 (1978).
87. Martin L, Claringbold PJ. The mitogenic action of oestrogens in the vaginal epithelium of the ovariectomized mouse. J Endocrinol 20:173-186 (1960).
88. Billings RE, McMahon RE. Microsomal biphenyl hydroxylation; the formation of 3-hydroxybiphenyl and biphenyl catechol. Mol Pharmacol 14:145-154 (1978).
89. Halpaap K, Horning MG, Horning EC. Metabolism of biphenyl in the rat. J Chromatography 166:479-490 (1978).
90. Matthews HB, Dedrick RL. Pharmacokinetics of PCBs. Annu Rev Pharmacol Toxicol 24:85-103 (1984).
91. Sipes IG, Schnellmann RG. Biotransformation of PCBs: metabolic pathways and mechanisms. Environ Toxin 1:98-110 (1987).
92. Kato S, McKinney JD, Matthews HD, Metabolism of symmetrical hexachlorobiphenyl isomers in the rat. Toxicol Appl Pharmacol 53:389-398 (1980).
93. Matthews HB, Anderson MW. Effect of chlorination on the distribution and excretion of polychlorinated biphenyls. Drug Metab Dispos 3:371-380 (1975).
94. Matthews HB, Tuey DB. The effect of chlorine position on the distribution and excretion of four hexachlorobiphenyl isomers, Toxicol Appl Pharmacol 53:377-388 (1980).
95. Green S, Walter P, Kumar V, Krust A, Bornert JM, Argos P, Chambon P. Human estrogen receptor cDNA: sequence, expression and homology. Nature 320:134-139 (1986).
96. Tora L, Mullick A, Metzger D, Ponglikitmongkol M, Park I, Chambon P. The cloned human estrogen receptor contains a mutation which alters its hormone binding properties. EMBO J 8:1981-1986 (1989).
97. Bokenkamp D, Jungblut PW, Thole HH. The c-terminal half of the porcine estradiol receptor contains no post-translational modification: determination of the primary structure. Mol Cell Endocrinol 104:163-172 (1994).
98. Madigou T, Tiffoche C, Lazennec G, Pelletier J, Thieulant M-L The sheep estrogen receptor: doning and regulation of expression in the hypothalamo-pituitary axis. Mol Cell Endocrinol 121:153-163 (1996).
99. Koike S, Sakai M, Muramatsu M. Molecular cloning and characterization of rat estrogen receptor cDNA. Nucleic Acids Res 15:2499-2513 (1987).
100. Spreafico E, Bettini E, Pollio G, Maggi A. Nucleotide sequence of estrogen receptor cDNA from Sprague-Dawley rat. Eur J Pharmacol 227:353-356 (1992).
101. White R, Lees JA, Needham M, Ham J, Parker M. Structural organization and expression of the mouse estrogen receptor. Mol Endocrinol 1:735-744 (1987).
102. Krust A, Green S, Argos P, Kumar V, Walter P, Bornert J-M, Chambon P. The chicken estrogen receptor sequence: homology with v-erbA and the human estrogen and glucocorticoid receptors. EMBO J 5:891-897 (1986).
103. Maxwell BL, McDonnell DP, Conneely OM, Schulz TZ, Greene GL, O'Malley BW. Structural organization and regulation of the chicken estrogen receptor. Mol Endocrinol 1:25-35 (1987).
104. Jacobs EC, Arnold AP, Campagnoni AT. Zebra finch estrogen receptor cDNA: cloning and mRNA expression. J Steroid Biochem Mol Biol 59:135-143 (1996).
105. Weiler IJ, Lew D, Shapiro DJ. The Xenopus laevis estrogen receptor: sequence homology with human and avian receptors and identification of multiple estrogen receptor messenger ribonucleic acids. Mol Endocrinol 1:355-362 (1987).
106. Pakdel F, Le Guellec C, Vailliant C, Le Roux MG, Valotaire Y. Identification and estrogen induction of two estrogen receptor (ER) messenger ribonucleic acids in the rainbow trout liver: sequence homology with other ERs. Mol Endocrinol 3:44-51 (1989).
107. Todo T, Adachi S, Yamauchi K. Molecular cloning and characterization of Japanese eel estrogen receptor cDNA. Mol Cell Endocrinol 119:37-45 (1996).
108. Mosselman S, Polman J, Dijkema R. ERβ: identification and characterization of a novel human estrogen receptor. FEBS Lett 392:49-53 (1996).
109. Kumar V, Green S, Stack G, Berry M, Jin JR, Chambon P. Functional domains of the human estrogen receptor. Cell 51:941-951 (1987).
110. Le Drean Y, Kern L, Pakdel F, Valotaire Y. Rainbow trout estrogen receptor presents an equal specificity but a differential sensitivity for estrogens than human estrogen receptor. Mol Cell Endocrinol 109:27-35 (1995).
111. Petit F, Valotaire Y, Pakdel F. Differential functional activities of rainbow trout and human estrogen receptors expressed in the yeast Saccharomyces cerevisiae. Eur J Biochem 233:584-592 (1995).
112. Tennant MK, Hill DS, Elderidge JC, Wetzel LT, Breckenridge CB, Stevens JT. Chloro-S-triazine antagonism of estrogen action: limited interaction with estrogen receptor binding. J Toxicol Environ Health 43:197-211 (1994).
113. Jobling S, Reynolds T, White R, Parker MG, Sumpter JP. A variety of environmentally persistent chemicals, including some phthalate plasticizers, are weakly estrogenic. Environ Health Perspect 103:582-587 (1995).
114. Fitzpatrick DW, Picken CA, Murphy LC, Buhr MM. Measurement of the relative binding affinity of zearalenol, α-zearalenol and β-zearalenol for uterine and oviduct estrogen receptors in swine, rats and chickens: an indicator of estrogenic potencies. Comp Biochem Physiol 94C:691-694 (1989).
115. Kuiper GGJM, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, Gustafsson J-A. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138:863-870 (1997).